OpenAlex
Drug resistance in ovarian cancer: from mechanism to clinical trial
Work
Year: 2024
Type: article
Abstract: Ovarian cancer is the leading cause of gynecological cancer-related death. Drug resistance is the bottleneck in ovarian cancer treatment. The increasing use of novel drugs in clinical practice poses ... more
Source: Molecular Cancer
Authors Ling Wang, Xin Wang, Xueping Zhu, Lin Zhong, Qingxiu Jiang +6 more
Institutions Chongqing Cancer Hospital, Chongqing University
Cites: 246
Cited by: 44
Related to: 10
FWCI: 38.42
Citation percentile (by year/subfield): 99.99
Topic: MicroRNA in disease regulation
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,888
Funders National Natural Science Foundation of China, Chongqing Science and Technology Commission
Grant IDS No. 82073129, No. CSTB2023NSCQ-MSX1030, No. cstc2022jxjl120039